loading
Greenwich Lifesciences Inc stock is traded at $12.16, with a volume of 46,666. It is down -5.52% in the last 24 hours and down -1.86% over the past month. Greenwich LifeSciences Inc is a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery. Its Product Candidates include; GP2, a HER2/neu transmembrane peptide that elicits a targeted immune response against HER2/neu-expressing cancers, GM-CSF Immunoadjuvant has been shown to enhance monocyte and neutrophil cytotoxicity against melanoma tumor cells and to enhance activity-dependent cellular cytotoxicity of monocytes and neutrophils against targets coated with the anti-ganglioside antibodies, and Cancer immunotherapy seeks to stimulate an individual's immune system to selectively attack cancer cells to inhibit the spread of cancer.
See More
Previous Close:
$12.87
Open:
$12.9
24h Volume:
46,666
Relative Volume:
1.47
Market Cap:
$159.84M
Revenue:
-
Net Income/Loss:
$-8.89M
P/E Ratio:
-17.37
EPS:
-0.7
Net Cash Flow:
$-6.48M
1W Performance:
+0.83%
1M Performance:
-1.86%
6M Performance:
-18.00%
1Y Performance:
+33.23%
1-Day Range:
Value
$12.03
$12.99
1-Week Range:
Value
$12.03
$13.10
52-Week Range:
Value
$8.00
$21.44

Greenwich Lifesciences Inc Stock (GLSI) Company Profile

Name
Name
Greenwich Lifesciences Inc
Name
Phone
203-434-3290
Name
Address
3992 BLUEBONNET DR, BUILDING 14, STAFFORD
Name
Employee
6
Name
Twitter
Name
Next Earnings Date
2024-11-08
Name
Latest SEC Filings
Name
GLSI's Discussions on Twitter

Compare GLSI with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
GLSI
Greenwich Lifesciences Inc
12.16 159.84M 0 -8.89M -6.48M -0.70
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
427.89 110.19B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
687.80 75.58B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
647.39 38.71B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
264.99 34.18B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
117.25 28.11B 3.30B -501.07M 1.03B -2.1146

Greenwich Lifesciences Inc Stock (GLSI) Upgrades & Downgrades

Date Action Analyst Rating Change
Sep-01-21 Initiated H.C. Wainwright Buy

Greenwich Lifesciences Inc Stock (GLSI) Latest News

pulisher
Jan 17, 2025

Glancy Prongay & Murray LLP Announces Investigation of Greenwich LifeSciences, Inc. (GLSI) - Marketscreener.com

Jan 17, 2025
pulisher
Jan 15, 2025

Long Term Trading Analysis for (GLSI) - Stock Traders Daily

Jan 15, 2025
pulisher
Jan 14, 2025

Greenwich LifeSciences Announces Partnership with GBG in Germany for Flamingo-01 - GlobeNewswire

Jan 14, 2025
pulisher
Jan 14, 2025

Greenwich LifeSciences expands trial sites in Germany - Investing.com India

Jan 14, 2025
pulisher
Jan 14, 2025

Greenwich Lifesciences Announces Partnership with GBG in Germany for Flamingo-01 - Marketscreener.com

Jan 14, 2025
pulisher
Jan 13, 2025

Greenwich LifeSciences CEO acquires $31,275 in common stock By Investing.com - Investing.com Australia

Jan 13, 2025
pulisher
Jan 13, 2025

Greenwich LifeSciences CEO acquires $31,275 in common stock - Investing.com India

Jan 13, 2025
pulisher
Jan 13, 2025

Greenwich LifeSciences, Inc. (NASDAQ:GLSI) CEO Snehal Patel Buys 2,500 Shares - MarketBeat

Jan 13, 2025
pulisher
Jan 13, 2025

Insider Buying: Snehal Patel Acquires Additional Shares of Green - GuruFocus.com

Jan 13, 2025
pulisher
Jan 13, 2025

Greenwich LifeSciences Partners with Unicancer Expanding Flamingo-01 into France - The Manila Times

Jan 13, 2025
pulisher
Jan 13, 2025

Greenwich LifeSciences Expands Phase III Breast Cancer Trial Across France with Unicancer Network - StockTitan

Jan 13, 2025
pulisher
Jan 09, 2025

Geode Capital Management LLC Raises Stock Holdings in Greenwich LifeSciences, Inc. (NASDAQ:GLSI) - Defense World

Jan 09, 2025
pulisher
Jan 09, 2025

Barclays PLC Increases Position in Greenwich LifeSciences, Inc. (NASDAQ:GLSI) - Defense World

Jan 09, 2025
pulisher
Jan 08, 2025

Greenwich Lifesciences CEO Snehal Patel buys $39,391 in stock By Investing.com - Investing.com Australia

Jan 08, 2025
pulisher
Jan 08, 2025

Insider Buying: Snehal Patel Increases Stake in Greenwich LifeSc - GuruFocus.com

Jan 08, 2025
pulisher
Jan 08, 2025

Greenwich LifeSciences, Inc. (NASDAQ:GLSI) CEO Purchases $24,750.00 in Stock - MarketBeat

Jan 08, 2025
pulisher
Jan 08, 2025

Greenwich Lifesciences CEO Snehal Patel buys $39,391 in stock - Investing.com India

Jan 08, 2025
pulisher
Jan 07, 2025

Greenwich Lifesciences CEO Snehal Patel acquires $44,030 in stock By Investing.com - Investing.com Canada

Jan 07, 2025
pulisher
Jan 07, 2025

Greenwich Lifesciences CEO Snehal Patel acquires $44,030 in stock - Investing.com

Jan 07, 2025
pulisher
Jan 06, 2025

Greenwich LifeSciences CEO Snehal Patel buys $23,940 in stock By Investing.com - Investing.com Australia

Jan 06, 2025
pulisher
Jan 06, 2025

Snehal Patel Buys 2,000 Shares of Greenwich LifeSciences, Inc. (NASDAQ:GLSI) Stock - MarketBeat

Jan 06, 2025
pulisher
Jan 06, 2025

Greenwich LifeSciences CEO Snehal Patel buys $23,940 in stock - Investing.com India

Jan 06, 2025
pulisher
Jan 04, 2025

(GLSI) Trading Report - Stock Traders Daily

Jan 04, 2025
pulisher
Jan 03, 2025

Greenwich LifeSciences CEO buys $27,264 in company stock By Investing.com - Investing.com Australia

Jan 03, 2025
pulisher
Jan 03, 2025

Greenwich LifeSciences CEO buys $27,264 in company stock - Investing.com India

Jan 03, 2025
pulisher
Jan 03, 2025

State Street Corp Raises Holdings in Greenwich LifeSciences, Inc. (NASDAQ:GLSI) - Defense World

Jan 03, 2025
pulisher
Jan 02, 2025

Greenwich Lifesciences CEO Snehal Patel acquires $35,584 in stock By Investing.com - Investing.com Canada

Jan 02, 2025
pulisher
Jan 02, 2025

Snehal Patel Purchases 3,200 Shares of Greenwich LifeSciences, Inc. (NASDAQ:GLSI) Stock - MarketBeat

Jan 02, 2025
pulisher
Jan 02, 2025

Greenwich Lifesciences CEO Snehal Patel acquires $35,584 in stock - Investing.com India

Jan 02, 2025
pulisher
Jan 01, 2025

Greenwich LifeSciences, Inc. (NASDAQ:GLSI) Short Interest Update - MarketBeat

Jan 01, 2025
pulisher
Dec 31, 2024

Insider Purchases Worth US$3.19m See Losses As Greenwich LifeSciences Market Value Drops To US$151m - Simply Wall St

Dec 31, 2024
pulisher
Dec 25, 2024

How to Take Advantage of moves in (GLSI) - Stock Traders Daily

Dec 25, 2024
pulisher
Dec 22, 2024

Greenwich LifeSciences (NASDAQ:GLSI) Reports Results of Annual Meeting - Defense World

Dec 22, 2024
pulisher
Dec 20, 2024

Greenwich LifeSciences reports shareholder meeting outcomes By Investing.com - Investing.com Australia

Dec 20, 2024
pulisher
Dec 20, 2024

Charles Schwab Investment Management Inc. Has $348,000 Stock Position in Vanguard International High Dividend Yield ETF (NASDAQ:VYMI) - Defense World

Dec 20, 2024
pulisher
Dec 20, 2024

Maiden Holdings, Ltd. (NASDAQ:MHLD) Shares Bought by Charles Schwab Investment Management Inc. - Defense World

Dec 20, 2024
pulisher
Dec 20, 2024

Invesco Dividend Achievers ETF (NASDAQ:PFM) Shares Sold by Charles Schwab Investment Management Inc. - Defense World

Dec 20, 2024
pulisher
Dec 20, 2024

Charles Schwab Investment Management Inc. Sells 3,312 Shares of scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World

Dec 20, 2024
pulisher
Dec 20, 2024

Charles Schwab Investment Management Inc. Sells 1,210 Shares of Oak Valley Bancorp (NASDAQ:OVLY) - Defense World

Dec 20, 2024
pulisher
Dec 20, 2024

Charles Schwab Investment Management Inc. Lowers Position in NexPoint Real Estate Finance, Inc. (NYSE:NREF) - Defense World

Dec 20, 2024
pulisher
Dec 20, 2024

Charles Schwab Investment Management Inc. Increases Position in Fresenius Medical Care AG (NYSE:FMS) - Defense World

Dec 20, 2024
pulisher
Dec 20, 2024

Charles Schwab Investment Management Inc. Has $351,000 Stock Holdings in Eos Energy Enterprises, Inc. (NASDAQ:EOSE) - Defense World

Dec 20, 2024
pulisher
Dec 20, 2024

Seven Hills Realty Trust (NASDAQ:SEVN) Shares Purchased by Charles Schwab Investment Management Inc. - Defense World

Dec 20, 2024
pulisher
Dec 20, 2024

Charles Schwab Investment Management Inc. Has $515,000 Stake in Endava plc (NYSE:DAVA) - Defense World

Dec 20, 2024
pulisher
Dec 20, 2024

Agenus Inc. (NASDAQ:AGEN) Shares Sold by Charles Schwab Investment Management Inc. - Defense World

Dec 20, 2024
pulisher
Dec 20, 2024

Charles Schwab Investment Management Inc. Grows Stock Position in Outlook Therapeutics, Inc. (NASDAQ:OTLK) - Defense World

Dec 20, 2024

Greenwich Lifesciences Inc Stock (GLSI) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$21.80
price up icon 4.81%
$73.47
price up icon 2.14%
$22.10
price up icon 16.13%
$367.97
price up icon 2.52%
biotechnology ONC
$218.70
price up icon 4.10%
$117.25
price up icon 4.75%
Cap:     |  Volume (24h):